06.10.25 -- The Matryoshka Model: The New Face Of Contract Packaging In Pharma

As drug sponsors continue to navigate increasing global demand for complex biologics, it is vital to assess which outsourcing strategies mitigate risk while maintaining budgets and timelines.

Accelerate your path from discovery to clinic by leveraging high-quality plasmid DNA, optimized expression systems, and early developability assessments to streamline transient protein production.

Intensified adherent cell culture offers a promising solution to the limitations of traditional suspension culture, with the potential to improve efficiency, reduce costs, and accelerate development.

While AI is an exciting area for the biopharmaceutical sector, other shorter-term and more tangible things can be done to get life-saving medicines to market faster.

An institute researching CRISPR-based genome editing required a custom, highly pure, ultra-low endotoxin nuclease. Learn how Aldevron's expertise helped to demonstrate reduced immune responses compared to using AAV serotype 9 for delivery.

Unlock the power of blended operator training and learn how combining digital tools with hands-on instruction reduces errors, boosts retention, and empowers your workforce for production success.